Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting
ASSAY and Drug Development Technologies · 01.07.2022 · 20 (5) · 211-224
DOI: 10.1089/adt.2022.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, erschienen am 01.07.2022. Verfasst von Dyandevi Mathure und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bharati Vidyappeth's Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Drug Carriers, Nanostructures. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bharati Vidyappeth's Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India.
- Abhinav Education Society's College of Pharmacy, Pune, Maharashtra, India.
- Department of Pharmaceutical Sciences, School of Health Sciences & Technology, University of Petroleum and Energy Studies (UPES), Dehradun, Uttarakhand, India.
ORCID-Profile: Rajendra Awasthi
Zitieren
APA
Mathure, D., Ranpise, H., Awasthi, R., & Pawar, A. (2022). Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting. ASSAY and Drug Development Technologies, 20(5), 211-224. https://doi.org/10.1089/adt.2022.044
Vancouver
Mathure D, Ranpise H, Awasthi R, Pawar A. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting. ASSAY and Drug Development Technologies. 2022;20(5):211-224. doi:10.1089/adt.2022.044
BibTeX
@article{Mathure2022,
author = {Mathure, Dyandevi and Ranpise, Hemantkumar and Awasthi, Rajendra and Pawar, Atmaram},
title = {Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting},
journal = {ASSAY and Drug Development Technologies},
year = {2022},
volume = {20},
number = {5},
pages = {211--224},
doi = {10.1089/adt.2022.044}
}
EUVIMED